Coronavirus | Five pharma firms join hands for Molnupiravir trial
The Hindu
First of its kind collaboration for testing COVID drug
Five pharma majors — Cipla, Dr. Reddy’s Laboratories, Emcure, Sun Pharma and Torrent — will collaborate for the clinical trials in India of investigational, oral, anti-viral drug Molnupiravir for the treatment of mild COVID-19 . Describing their collaboration as a first of its kind in the Indian pharma industry, a release on Tuesday said the companies will jointly sponsor, supervise and monitor the clinical trial that is expected to take place between June and September this year. The trial, for which 1,200 patients are to be recruited, is to be conducted across the country.More Related News

At least five killed, seven injured as car rams into stationary vehicle near Tamil Nadu’s Keelakarai
A tragic road accident on ECR near Keelakarai leaves five dead and seven injured, involving a DMK functionary’s vehicle.












